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Abstract
Background Italy is one of the most affected countries by the coronavirus disease 2019 (COVID-19). The responsible patho-
gen is named severe acute respiratory syndrome coronavirus (SARS-CoV-2). The clinical spectrum ranges from asymptomatic 
infection to severe pneumonia, leading to intensive care unit admission. Evidence of cerebrovascular complications associ-
ated with SARS-CoV-2 is limited. We herein report six patients who developed acute stroke during COVID-19 infection.
Methods A retrospective case series of patients diagnosed with COVID-19 using reverse-transcriptase polymerase chain 
reaction (RT-PCR) on nasopharyngeal swabs, who developed clinical and neuroimaging evidence of acute stroke during 
SARS-CoV-2 infection.
Results Six patients were identified (5 men); median age was 69 years (range 57–82). Stroke subtypes were ischemic (4, 67%) 
and hemorrhagic (2, 33%). All patients but one had pre-existing vascular risk factors. One patient developed encephalopathy 
prior to stroke, characterized by focal seizures and behavioral abnormalities. COVID-19-related pneumonia was severe (i.e., 
requiring critical care support) in 5/6 cases (83%). Liver enzyme alteration and lactate dehydrogenase (LDH) elevation were 
registered in all cases. Four patients (67%) manifested acute kidney failure prior to stroke. Four patients (67%) had abnor-
mal coagulation tests. The outcome was poor in the majority of the patients: five died (83%) and the remaining one (17%) 
remained severely neurologically affected (mRS: 4).
Conclusions Both ischemic and hemorrhagic stroke can complicate the course of COVI-19 infection. In our series, stroke 
developed mostly in patients with severe pneumonia and multiorgan failure, liver enzymes and LDH were markedly increased 
in all cases, and the outcome was poor.
Keywords COVID-19 · Coronavirus · Encephalitis · Cerebrovascular disease · Neurological complications · Brain 
hemorrhage
Introduction
Italy was the first country in Europe to witness an outbreak 
of the coronavirus disease 2019 (COVID-19), which, as 
of April 6, has infected 1,277,196 people worldwide [1]. 
The responsible pathogen is named severe acute respiratory 
syndrome coronavirus (SARS-CoV-2). The clinical spec-
trum associated with COVID-19 ranges from asymptomatic 
infection to severe pneumonia, leading to intensive care unit 
(ICU) admission [2–4]. Evidence of cerebrovascular compli-
cations associated with SARS-CoV-2 is limited, but previous 
reports from the SARS epidemic in Asia in 2003 suggested a 
higher incidence of thromboembolic complications, includ-
ing stroke [5]. Management of acute stroke in the setting of 
this pandemic disease poses unique challenges, including 
the need to maintain high-quality stroke care with limited 
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resources, while at the same time preventing infection spread 
to patients and physicians [6]. A better characterization of 
cerebrovascular complications associated with COVID-19 
infection is important to guide decision making.
We herein report the clinical spectrum, neuroimaging 
findings, and outcome of six patients developing acute stroke 
during COVID-19 infection.
Methods
This is a retrospective observational case series of patients 
developing clinical and neuroimaging evidence of acute 
stroke during COVID-19 infection. We included only 
patients with laboratory-confirmed COVID-19 infection 
who were admitted to the Fondazione Poliambulanza Hos-
pital, Brescia, Italy, or the Udine University Hospital, Udine, 
Italy, between March 16 and April 5, 2020. A confirmed 
case of COVID-19 was defined by a positive result on a 
reverse-transcriptase polymerase chain reaction (RT-PCR) 
assay on nasopharyngeal swabs. Demographic data, infor-
mation on clinical presentation and evolution, and laboratory 
and radiologic results were recorded. The severity of acute 
respiratory distress syndrome (ARDS) was rated using the 
 PaO2/FiO2 ratio (partial pressure of arterial oxygen over the 
fraction of inspired oxygen) which was indicated whenever 
available. Acute lung injury is present if  PaO2/FiO2 ratio 
is ≤ 300 [7]. Each diagnosis of stroke was confirmed by brain 
computed tomography (CT)/CT angiography (CTA), and/or 
magnetic resonance imaging (MRI). All examinations were 
reviewed by two experienced neuroradiologists (DB, MM). 
Neurological presentations were reviewed by one experi-
enced neurologist (AV). Descriptive analysis is presented as 
frequencies and percentages for categorical variables and as 
the median and range for continuous variables. All proce-
dures were performed in accordance with the institutional 
ethics committee and the Declaration of Helsinki.
Results
Six patients were identified (5 men); median age was 
69 years (range 57–82). Stroke subtypes were ischemic (4, 
67%) and hemorrhagic (2, 33%). All patients but one had 
pre-existing vascular risk factors. COVID-19-related pneu-
monia was severe (i.e., requiring critical care support) in 
5/6 cases (83%). Liver enzyme alteration and lactate dehy-
drogenase elevation were registered in all cases (100%). 
Four patients (67%) manifested acute kidney failure prior to 
stroke. Four patients (67%) had abnormal coagulation tests. 
Cerebrovascular complications were multiple and bilateral 
in four cases (67%). The outcome was poor in the major-
ity of the patients: five died (83%), and the remaining one 
(17%) remains severely neurologically affected (mRS: 4). 
Table 1  Characteristics of patients with cerebrovascular complications of SARS-CoV-2 infection
Case no. (age, 
sex)
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Severe  +  +  +  + (↑ INR) Death





Severe  +  +  + No Death






Moderate No  +  +  + (↑ D-dimer) mRS = 4
5 (57, M) Hemorrhagic Arterial hyper-
tension, throm-
bocytosis
Severe  +  +  +  + (↑ aPTT, ↑ 
D-dimer)
Death
6 (57, M) Hemorrhagic None Severe No  +  + No Death
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Clinical and laboratory data for all patients are summarized 
in Table 1.
Case 1
A 64-year-old man presented with cough, fever, and dysp-
nea for 6 days. He had a previous history of smoking, but 
he was not a current smoker. Due to an acute myocardial 
infarction, he underwent a percutaneous coronary interven-
tion 13 years earlier. His treatment included dual antiplatelet 
therapy (aspirin and clopidogrel) and ramipril. Body tem-
perature at admission was 38.6 °C. Clinical and laboratory 
findings indicated moderate respiratory distress  (PaO2/FiO2 
238). Chest X-ray demonstrated bilateral areas of consolida-
tion. The respiratory function progressively worsened and 
3 days later he was intubated and mechanically ventilated. 
In the following days, the patient developed kidney failure 
(creatinine 3.22 mg/dL, n.v. 0.72–1.18), increased indices of 
inflammation and hepatic injury (C-reactive protein [CRP] 
175 mg/L, n.v. < 5; lactate dehydrogenase [LDH] 1032 IU/L, 
n.v. 125–220; aspartate aminotransferase [AST] 152 IU/L, 
n.v. 4–40; gamma-glutamyltransferase [GGT] 1165 IU/L, 
n.v. 8–61; total bilirubin 6.64 mg/dL, n.v. 0.2–1) and neuro-
logical deterioration, with inability to arouse during sedation 
lightening. All these features together were suggestive of 
multiorgan failure. Coagulation tests showed thrombocyto-
penia (78 × 103/µL, n.v. 150–400) associated with increased 
international normalized ratio (INR 1.62, n.v. 0.80–1.20) 
and increased D-dimer (7744 ng/mL, n.v. 0–500). On day 
16, a total body CT demonstrated extensive bilateral consoli-
dations and ground-glass opacities of the lungs with bilateral 
pleural effusion (Fig. 1a) and a filling defect in the right 
pulmonary artery due to pulmonary embolism. A cuneiform 
hypodense area was also detected in the spleen (Fig. 1b). 
Brain CT showed multiple hypodense lesions involving dif-
ferent cortical and subcortical regions of both cerebral hemi-
spheres (Fig. 1c and d). Clinical, laboratory and imaging 
findings were consistent with pulmonary thrombo-embolism 
associated with multiple ischemic lesions involving the brain 
and spleen. Three days after CT examination, the patient 
died.
Case 2
A 75-year-old man with diabetes mellitus and arterial 
hypertension presented with cough and fever for 5 days. His 
treatment included metformin and anti-hypertensive drugs 
(enalapril and hydrochlorothiazide). Body temperature at 
admission was 38.9 °C. Clinical and laboratory findings 
indicated mild respiratory distress  (PaO2/FiO2 347). Chest 
CT demonstrated bilateral ground-glass opacities (Fig. 1e). 
On day 12, the respiratory function worsened and the patient 
was found unconscious with severe hypoxemia  (SO2 76%) 
and left-sided hemiparesis. Brain CT and CTA showed 
cortico-subcortical hypodensity over the right cingulate 
gyrus (Fig. 1f–g) with occlusion of the right pericallosal 
Fig. 1  Total body and brain CT examination of Patient 1 a–d show-
ing extensive bilateral consolidations and ground-glass opacities of 
the lungs (a), a hypodense area in the upper portion of the spleen (b) 
and two different ischemic lesions involving the left occipital lobe 
(c) and the right frontal precentral gyrus (d), respectively. Chest and 
brain CT examination of Patient 2 e–h showing bilateral consolida-
tions and ground-glass opacities of the lungs with pleural effusion on 
the left side (e), an ischemic lesion involving the frontal lobe on the 
right side (f–g), and the occlusion of the right pericallosal artery on 
a 3D-volume rendering reconstruction of the brain CT angiography 
examination (h)
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artery (Fig. 1h). The same day, the patient was transferred 
to ICU where he was intubated and mechanically ventilated. 
Blood tests were significant for increased CRP (46 mg/L, 
n.v. < 5), creatinine (5 mg/dL), liver enzymes (alanine ami-
notransferase [ALT] 74 IU/L, n.v. < 60), LDH (979 IU/L, 
n.v. 125–220), and INR (INR 1.53, n.v. 0.80–1.20). On day 
21, the patient’s neurological status further declined, with 
a Glasgow Coma Scale (GCS) of 3. New brain CT showed 
multiple, bilateral, supratentorial (right frontal and parietal, 
left perirolandic and bilateral occipital) and infra-tentorial 
(vermian, left cerebellar hemisphere) ischemic lesions. Chest 
CT showed extension of ground-glass opacities and consoli-
dations (involving about 75% of the lung parenchyma). Elec-
troencephalogram (EEG) demonstrated bilateral slowing of 
the background rhythm with frontal sharp waves. On day 38, 
he developed hemodynamic instability and died.
Case 3
An 82-year-old man presented with cough, fever, and dysp-
nea for 7 days. He had a previous history of mild diabetes 
mellitus, hypertensive cardiomyopathy, aortic valve regurgi-
tation, and previous transitory ischemic attack. His treatment 
included aspirin and telmisartan, but not insulin. In 2015, 
he underwent left carotid endarterectomy. Body temperature 
at admission was 37.9 °C. Clinical and laboratory evalua-
tion showed moderate respiratory distress  (PaO2/FiO2 198), 
increased creatinine (1.22 mg/dL, n.v. 0.72–1.18), CRP 
(181 mg/L, n.v. < 5), and LDH (507 IU/L, n.v. 125–220). 
Coagulation tests were normal. Chest radiography demon-
strated hazy ground-glass opacities involving the peripheral 
and basal regions of the lungs with no significant pleural 
effusion (Fig. 2a). The next day, he developed left-sided 
hemiparesis. Brain CT examination showed a new small 
hypodense area in the right thalamus of presumed ischemic 
origin (Fig. 2b, initial imaging; c, with ischemic lesion). 
CT-angiography showed no intra-luminal filling defect in the 
carotid arteries, vertebrobasilar system, and other intra-cra-
nial vessels. During hospitalization, he was treated with dual 
antiplatelet therapy (aspirin and clopidogrel) together with 
enoxaparin. On day 3, a new brain CT showed appearance of 
an additional small hypodense area in the centrum semiovale 
(Fig. 2d). No intra-axial hemorrhages were detected. On day 
4, the patient rapidly became comatose and died.
Case 4
A 76-year-old woman presented with cough and fever for 
10 days. The patient had a previous history of arterial hyper-
tension, diabetes mellitus, aortic valve replacement, and cer-
ebellar stroke. Her treatment included aspirin and warfarin. 
Body temperature at admission was 37.6 °C. Clinical and 
laboratory evaluation indicated mild respiratory distress 
 (PaO2/FiO2 261). Chest CT demonstrated multiple areas of 
ground-glass opacities and consolidations mainly involving 
the lower lobes (Fig. 2e). The family members reported a 
Fig. 2  Chest X-ray and two different brain CT examinations of 
Patient 3 a–d showing multiple opacities involving both lungs and a 
left lower lobe consolidation (a), the normal aspect of both thalami 
(b) and the appearance few days later of multiple ischemic lesions 
involving the right thalamus (c), and the subcortical white matter 
of the centrum semiovale of the same side (d). Chest CT and brain 
MRI examinations of patient 4 e–h, demonstrating multiple areas of 
ground-glass opacities and consolidations mainly involving the lower 
lobes (e), a focal T2-FLAIR hyperintensity lesion in the left precen-
tral gyrus (f) with a bright signal on DWI sequence (g), and mild 
post-contrast enhancement of the head of the right caudate nucleus 
(h)
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number of episodes of transient loss of consciousness, fol-
lowed by confusion, in the days preceding admission to 
the hospital. Blood tests showed increased CRP (12 mg/L, 
n.v. < 5) and D-dimer (1381 ng/mL, n.v. 0–500). On day 4, 
EEG showed a normal background in the alpha range (8 Hz), 
associated with recurrent sharp slow waves over the left tem-
poral region, which occasionally were seen also on the right 
homologous regions. The episodes were interpreted as focal 
seizures and treatment with levetiracetam was introduced. 
A brain CT demonstrated a small hypodense area (5 mm) in 
the head of the right caudate nucleus referable to a lacunar 
infarction. On day 5, a contrast-enhanced brain MRI showed 
a small rounded area of diffusion restriction on the left pre-
rolandic gyrus (Fig. 2f, fluid attenuated inversion recovery 
[FLAIR] imaging; g, diffusion-weighted imaging [DWI]). 
The lesion previously noted in the right caudate nucleus was 
hyperintense on T2-FLAIR, with no diffusion restriction 
but faint contrast enhancement (Fig. 2h). A small cortical-
leptomeningeal area of enhancement was also noted in the 
left middle frontal gyrus at the level of the superior frontal 
sulcus. T2* GRE revealed no hypointense lesions consistent 
with hemorrhagic lesions. Brain MRI angiography showed 
no alterations of intracranial vessels. In the following days, 
the patient remained confused and demonstrated severe 
behavioral abnormalities, including delirium and aggressive-
ness. Cerebrospinal fluid analysis demonstrated normal pro-
tein content (0.5 g/L), 0 leukocyte, and normal IgG index. A 
comprehensive autoimmune screening was unrevealing. On 
day 10, a new EEG excluded non-convulsive status epilepti-
cus, while showing persistence of sharp slow waves, mainly 
over the left hemispheric regions. At the last follow-up, 
14 days after admission, patient’s neurological conditions 
were only partially improved (mRS = 4).
Case 5
A 57-year-old man presented with fever and cough for a 
week with associated dyspnea for 3 days. He had a previ-
ous history of hypertension and thrombocytosis. Treatment 
included acetylsalicylic acid, hydroxyurea, and ramipril. 
Body temperature at admission was 38.4 °C. Clinical and 
laboratory evaluation showed moderate respiratory distress 
 (PaO2/FiO2 191). Chest CT demonstrated diffuse bilateral 
ground-glass opacities with no pleural effusion (Fig. 3a). 
The respiratory function progressively worsened during the 
following days and, on day 3, he was transferred to ICU for 
invasive ventilation. The patient received 4000 IU enoxa-
parin daily subcutaneously for prevention of venous throm-
boembolic disease. On day 4, he developed kidney failure 
(creatinine 3.24 mg/dL) treated with veno-venous hemofil-
tration (CVVH). Indices of inflammation and hepatic injury 
were increased (CRP 214 mg/L, n.v. < 5; LDH 1013 U/L, 
n.v. 125–220; AST 97 U/L, n.v. < 35; GGT 454 U/L, n.v. 
8–61). 11 days after admission, the patient was found with 
bilaterally fixed and dilated pupils and a GCS of 3. Coagula-
tion tests revealed prolonged aPTT (53.1 s, n.v. 23.5–35.0) 
Fig. 3  Chest and brain CT examination of Patient 5 (a–d), show-
ing diffuse bilateral ground-glass opacities involving both lungs (a), 
a large cerebellar hemorrhage (b) which compresses the brainstem 
and the fourth ventricle determining a subsequent obstructive hydro-
cephalus (c, d). Chest and brain CT examination of Patient 6 (e–h), 
demonstrating diffuse bilateral ground-glass opacities with no pleural 
effusion (e), diffuse cerebral edema with loss of normal gray–white 
matter differentiation and obliteration of CSF spaces (f), a large right 
frontal hemorrhage in association with other smaller hemorrhages on 
the axial and on the coronal multiplanar reconstruction of brain CT 
(g, h), and a bright spot within the sagittal sinus suspected for dural 
sinus thrombosis
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and increased D-dimer (2866 ng/mL, n.v. 0–500). A brain 
CT demonstrated hemorrhages (Fig. 3b, c) in both cerebellar 
hemispheres (diameter of 4.8 cm on right, and 3.6 cm on the 
left) with compression of the fourth ventricle and the brain-
stem. Supratentorial hydrocephalus and diffuse obliteration 
of sulci were also noted (Fig. 3d). CTA did not support the 
possibility of venous infarction due to non-opacification 
of the venous vessels. One hour after CT examination, the 
patient died.
Case 6
A previously healthy 57-year-old man presented with 
cough and fever for 10 days with associated dyspnea for 
4 days. Body temperature at admission was 37.5 °C. Clini-
cal and laboratory evaluation showed respiratory insuffi-
ciency  (PaO2/FiO2 197), increased CRP (21 mg/L, n.v. < 5), 
and alteration of the hepatic function (LDH 771 U/L, n.v. 
125–220; AST 100 U/L, n.v. 4–40; GGT 152 U/L, n.v. 
8–61). Chest CT demonstrated diffuse bilateral ground-
glass opacities with no pleural effusion (Fig. 3e). On day 5, 
his respiratory function worsened and he was transferred to 
ICU for invasive ventilation. He was treated with 4000 IU 
enoxaparin daily subcutaneously. Despite regular cardiac 
activity and well-supported respiratory function, 7 days 
after admission in ICU his neurological conditions suddenly 
deteriorated. The patient was found with bilaterally fixed 
and dilated pupils, with a GCS of 3. A brain CT (Fig. 3f–h) 
demonstrated diffuse cerebral edema with a large right fron-
tal hemorrhage (6.0 × 5.2 cm on the axial plane) extending to 
the ventricular system. The ventricles were displaced across 
the midline. Four additional smaller intra-axial hemorrhages 
occurred in both hemispheres. Coagulation tests were nor-
mal. Shortly after CT examination, the patient died.
Discussion
We report the clinical and neuroimaging features of six 
patients with severe SARS-CoV-2 infection who developed 
acute stroke, four ischemic and two hemorrhagic.
At the time the cerebrovascular complications ensued, all 
but one patient needed critical care support and most of them 
had evidence of multiorgan failure. Most of the patients were 
elderly male with comorbidities. Ischemic lesions were typi-
cally multiple and bilateral, suggesting an embolic etiology. 
Conversely, the detection of simultaneous multiple intrac-
erebral hemorrhages associated with severe brain edema is 
unprecedented in this setting and raises important issues in 
the management of patients with Covid-19. Taken together, 
these factors could account for the poor outcome observed 
in this cohort. Given the fact that vascular risk factors were 
frequent, the association between SARS-CoV-2 and stroke 
might be coincidental. Nevertheless, a body of epidemio-
logical, clinical and experimental evidence suggests that 
patients with COVID-19 are at higher risk of thromboem-
bolic complications, including neurovascular diseases, in the 
acute phase of infection. In particular, previous experiences 
from other coronavirus-related diseases, the 2003 SARS 
epidemic and the 2012 Middle East respiratory syndrome 
(MERS), have highlighted stroke, pulmonary embolism 
and myocardial infarction as possible complications, espe-
cially in critically ill patients [5, 8]. Additionally, a recent 
report from Wuhan, China, showed that acute cerebrovas-
cular disease is not uncommon in COVID-19, and it rep-
resents a negative prognostic factor. Among 221 infected 
patients, 11 (5%) developed ischemic stroke, 1 (0.5%) cer-
ebral venous thrombosis, and 1 (0.5%) brain hemorrhage 
[9]. In agreement with the finding of the present study, it 
was also observed that cardiovascular risk factors were com-
mon, while the patients demonstrated increased biomarkers 
of inflammatory response as well as a hypercoagulable state 
[9].
The relationship between acute infection and stroke is com-
plex and it was demonstrated for many types of bacterial and 
viral infections. Importantly, an increased risk of stroke was 
documented after respiratory infections, including influenza, 
and the risk was highest within the first week [10]. Accord-
ingly, measures to prevent viral illnesses (e.g., influenza vac-
cination) were shown to be protective for the development 
of cerebrovascular disease [11]. Intriguingly, the association 
between infection and stroke is also relevant for patients with 
preexistent risk factors. In this group, the vulnerability of ath-
erosclerotic plaques to rupture appears to be increased in the 
presence of systemic inflammation and sepsis [10]. The mech-
anisms by which viral infections can trigger stroke are multiple 
and depend on the associated pathogen and host characteris-
tics. For example, varicella zoster virus (VZV) is responsible 
for a distinctive vasculopathy involving both large and small 
arteries, which can result in ischemic infarction of the brain 
and spinal cord, as well as subarachnoid and cerebral hemor-
rhage [12]. At autopsy, the cerebral arteries showed disruption 
of the internal elastic lamina and multinucleated giant cells, 
while the presence of VZV DNA was demonstrated in the 
posterior cerebral and basilar arteries [13]. Similarly, human 
immunodeficiency virus (HIV) is a known cause of large ves-
sel vasculopathy (mainly aneurysmal) that can also involve 
the brain [14]. A vasculitic-like mechanism can also apply in 
the context of COVID-19, since localized fibrinoid necrosis 
as well as infiltration of monocytes, lymphocytes, and plasma 
cells into vessel walls were demonstrated in three cases of the 
2003 SARS disease [15]. Interestingly enough, another type of 
coronavirus (New Haven CoV) was associated with the devel-
opment of systemic vasculitis of childhood (Kawasaki disease) 
in a case–control study [16]. An alternative mechanism leading 
to stroke during the course of an infection is the presence of a 
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pro-thrombotic state. Numerous reports have documented vari-
ous coagulation abnormalities (in particular, raised D-dimer, 
thrombocytopenia, and isolated prolonged aPTT) in patients 
with SARS-CoV, nearly two decades ago [17, 18]. Chong et al. 
studied an autopsy series of eight SARS patients and demon-
strated the presence of pulmonary embolism in half of them, 
while one patient developed non-bacterial valvular vegetations 
associated with infarctions of the heart, kidneys, spleen, and 
occipital lobe [18]. Similarly, an underlying thrombophilic 
state can also be hypothesized in SARS-CoV-2 infection, as 
suggested by a report of pulmonary embolism in patients from 
Wuhan [19] and in Patient 1 of the present series who also 
presented brain and spleen lesions suggestive for embolization.
We observed a marked elevation of a ubiquitous cell 
enzyme (LDH) in all patients of the present series. Elevated 
serum LDH is associated with numerous clinical conditions, 
including hemolysis, cancer, and sepsis [20]. In the setting of 
COVID-19, it is possible that the very high LDH levels reflect 
the underlying respiratory failure and systemic shock. Its role 
as a potential prognostic factor in COVID-19-associated stroke 
should be further investigated.
No patient with ischemic stroke was treated with throm-
bolysis or thrombectomy in the present series. This could be 
related to the fact that the patients were critically ill, and the 
detection of changes in neurological status is highly complex 
in ICU patients, where lightening of sedation and frequent 
neurological follow-up are needed. All these measures can be 
less prompt in the presence of restricted resources and limited 
medical personnel, as in a catastrophic medical emergency 
like COVID-19.
Finally, one patient (Case 4) developed an encephalopathy, 
characterized by focal seizures in association with behavioral 
abnormalities, which preceded stroke, and complicated hos-
pital stay. No clear structural, autoimmune, or metabolic etiol-
ogy was found. Given the fact that cases of encephalitis and 
encephalopathy linked to COVID-19 were recently reported 
[21], we cannot exclude that it was due to direct neuro-inva-
sion of SARS-CoV-2, although we are unable to prove this 
hypothesis.
In conclusion, acute stroke can complicate the course of 
COVID-19 infection.
Both ischemic and hemorrhagic lesions are possible, fur-
ther underscoring the delicate equilibrium between thrombo-
philic state and coagulopathy in patients with SARS-CoV-2. 
In our series, stroke developed mostly in patients with severe 
pneumonia and multiorgan failure, liver enzymes and lactate 
dehydrogenase were markedly increased in all cases, and the 
outcome was poor.
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